Rethinking Neurology Education With AI: A Preview of ANA/AUPN 2025
July 18th 2025Elisabeth Marsh, MD, an associate professor of neurology at Johns Hopkins, shared her insights on the emerging role of AI in clinical practice and neurologic education, ahead of her session at the 2025 ANA/AUPN Annual Meetings.
International Case Series Reveals Meningitis as a Potential Underrecognized Feature of MOGAD
July 17th 2025A recent research letter emphasized that meningitis could be a possible early manifestation of MOG antibody–associated disease, according to results previously published in an international study.
Overviewing the Clinical use of the CARM Score in Alzheimer Disease Detection: James Galvin, MD
July 17th 2025The professor of neurology at the University of Miami Miller School of Medicine provided context on the clinical use of the Cognivue Amyloid Risk Measure in the context of Alzheimer disease care. [WATCH TIME: 3 minutes]
Debate on Glymphatic System Reexamines Sleep’s Role in Alzheimer Disease Pathology
July 17th 2025Andrew Varga, MD, PhD, associate professor of medicine at the Icahn School of Medicine at Mount Sinai, provided comment on a featured debate at the 2025 SLEEP Annual Meeting exploring the evolving science behind glymphatic clearance and its potential link to Alzheimer disease.
How Simulations Can Improve Non-Clinical Competencies in Neurology Education
July 17th 2025Nuri Jacoby, MD, neurologist at Maimonides Medical Center and SUNY Downstate, previewed a hands-on session at the upcoming AUP Annual Meeting exploring how simulations can teach communication, professionalism, and feedback skills in neurology training.
Advancing Non-Opioid Neurosurgerical Solutions for Refractory Pain Conditions
July 16th 2025Nester Tomycz, MD, director of neurosurgical pain division at Allegheny General Hospital, discussed emerging neurosurgerical approaches for chronic pain, with a focus on neuromodulation, patient selection, and non-opioid treatment pathways.
Expanding Diagnostic Tools for iRBD Through Actigraphy-Based Classifiers
July 15th 2025Emmanuel During, MD, an associate professor of neurology at the Icahn School of Medicine at Mount Sinai, discussed the external validation of an actigraphy-based classifier for diagnosing iRBD and its implications for scalable neurodegenerative screening.
Late-Breaking Phase 2b PARADIGM Data Support Continued Development of PrimeC in ALS
July 14th 2025Recently reported phase 2b results revealed that PrimeC consistently altered ALS-related miRNA expression, reinforcing its potential as a multi-targeted therapy and aligning with previously reported clinical benefits.
Centering Empathy in Parkinson Care by Listening Beyond the Diagnosis: María L. De León, MD
July 14th 2025The movement disorder specialist and patient living with Parkinson disease highlighted the need for a more human-centered approach in managing chronic and progressive movement disorders. [WATCH TIME: 6 minutes]